Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • UNITED THERAPEUTICS CORP DEL Analyst Recommendations

  • Analyst Consensus: UTHR

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 1.842 Buy 19
    30 Days Ago 1.947 Buy 19
    60 Days Ago 1.842 Buy 19
    90 Days Ago 1.842 Buy 19
    120 Days Ago 1.474 Strong Buy 19

  • Analyst Ratings: UTHR

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    JP Morgan Overweight Neutral 08/03/2009 —
    Benchmark — Buy 07/31/2009 95.00
    Wedbush Morgan Outperform Neutral 07/31/2009 109.00
    Wedbush Morgan — Outperform 07/27/2009 106.00
    Auriga U.S.A — Buy 07/20/2009 108.00
    Lazard Capital Mkts — Buy 06/23/2009 103.00
    Soleil — Buy 05/19/2009 91.00
    Maxim Group — Buy 05/14/2009 96.00
    Auriga U.S.A — Buy 05/04/2009 83.00
    FTN Equity Capital Neutral Buy 05/04/2009 79.00
    Brean Murray — Buy 05/01/2009 104.00
    Barclays Capital Overweight Equal Weight 04/20/2009 —
    Lazard Capital Mkts — Buy 04/06/2009 98.00
    Ladenburg Thalmann — Buy 03/17/2009 112.00
    Jefferies & Co — Buy 03/17/2009 80.00
    Wedbush Morgan — Strong Buy 03/16/2009 97.00
    FTN Equity Capital — Neutral 03/12/2009 —
    Collins Stewart — Buy 03/03/2009 97.00
    Piper Jaffray Sell Neutral 11/19/2008 —
    Ladenburg Thalmann — Buy 11/18/2008 118.00
    Brean Murray — Buy 11/17/2008 114.00
    Deutsche Securities — Buy 11/11/2008 —
    Brean Murray Hold Buy 10/17/2008 125.00
    Jefferies & Co — Buy 09/24/2008 141.00
    Stanford Research Hold Buy 09/19/2008 151.00
    Piper Jaffray — Sell 08/12/2008 —
    Ladenburg Thalmann — Buy 08/01/2008 134.00
    Rodman & Renshaw — Mkt Outperform 08/01/2008 141.00
    Stanford Research Buy Hold 07/07/2008 101.00
    Leerink Swann — Outperform 05/19/2008 150.00
    Next